Kelle Moley

Global VP Of Clinical And Translational R&d, Reproductive Medicine And Maternal Health at Ferring Pharmaceuticals

Kelle Moley has a varied and extensive work experience in the field of reproductive medicine and maternal health. Kelle is currently serving as the Global VP of Clinical and Translational R&D at Ferring Pharmaceuticals, focusing on reproductive medicine and maternal health. Prior to this, they held the position of VP of Science and Public Affairs at Ferring Pharmaceuticals, as well as VP of Science and Medical Affairs.

Before joining Ferring Pharmaceuticals, Kelle Moley worked at the Bill & Melinda Gates Foundation, where they served as the Deputy Director of Reproductive Health Technologies within the Global Health department. Kelle also held the role of Chief Scientific Officer at the March of Dimes, where they contributed to advancements in the field of reproductive health.

Kelle Moley's academic background includes being an Adjunct Professor at Washington University in St. Louis and a Professor and Vice Chair at Washington University School of Medicine. Kelle has been actively involved in academic research and teaching for many years.

Overall, Kelle Moley's work experience showcases their expertise in reproductive medicine and maternal health, as well as their commitment to advancing scientific knowledge and improving global health outcomes.

Kelle Moley obtained a Bachelor of Arts (BA) degree in Biochemistry and Molecular Biology from Wellesley College in the years 1980-1984. Subsequently, they pursued their Doctor of Medicine (MD) at the Yale University School of Medicine from 1984 to 1988. There is no available information regarding any additional education at Washington University School of Medicine in St. Louis or Washington University in St. Louis.

Links

Previous companies

March of Dimes logo
Bill & Melinda Gates Foundation logo

Peers

View in org chart

Timeline

  • Global VP Of Clinical And Translational R&d, Reproductive Medicine And Maternal Health

    February, 2023 - present

  • VP Of Science And Public Affairs

    September, 2022